#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA812862	F	Inhibition dose for AVP (30 milliunits/kg, iv) induced vasoconstriction when orally administarted		6		organism-based format	Scientific Literature
2.	ALA812863	F	Inhibition expressed as percent change in diastolic blood pressure increased by AVP (30 milliunits / kg, iv) before and after oral administration at 19 uM/kg; No effect		1		organism-based format	Scientific Literature
3.	ALA812864	F	Inhibition expressed as percent change in diastolic blood pressure increased by AVP (30 milliunits / kg, iv) before and after oral administration at 20 uM/kg		1		organism-based format	Scientific Literature
4.	ALA812865	F	Inhibition expressed as percent change in diastolic blood pressure increased by AVP (30 milliunits / kg, iv) before and after oral administration at 20 uM/kg); No effect		1		organism-based format	Scientific Literature
5.	ALA818113	F	Inhibition expressed as percent change in diastolic blood pressure increased by AVP (30 milliunits / kg, iv) before and after oral administration at 21 uM/kg		3		organism-based format	Scientific Literature
6.	ALA818114	F	Inhibition expressed as percent change in diastolic blood pressure increased by AVP (30 milliunits / kg, iv) before and after oral administration at 22 uM/kg		1		organism-based format	Scientific Literature
7.	ALA818115	F	Inhibition expressed as percent change in diastolic blood pressure increased by AVP (30 milliunits / kg, iv) before and after oral administration at 22 uM/kg; No effect		1		organism-based format	Scientific Literature
8.	ALA815431	F	Inhibition expressed as percent change in diastolic blood pressure increased by AVP (30 milliunits / kg, iv) before and after oral administration at 23 uM/kg		2		organism-based format	Scientific Literature
9.	ALA815432	F	Inhibition expressed as percent change in diastolic blood pressure increased by AVP (30 milliunits / kg, iv) before and after oral administration at 240 uM/kg); No effect		1		organism-based format	Scientific Literature
10.	ALA815433	F	Inhibition expressed as percent change in diastolic blood pressure increased by AVP (30 milliunits / kg, iv) before and after oral administration at 270 uM/kg		1		organism-based format	Scientific Literature
11.	ALA815434	F	Inhibition expressed as percent change in diastolic blood pressure increased by AVP (30 milliunits / kg, iv) before and after oral administration at 290 uM/kg		1		organism-based format	Scientific Literature
12.	ALA815435	F	Inhibition expressed as percent change in diastolic blood pressure increased by AVP (30 milliunits / kg, iv) before and after oral administration at 76 uM/kg (n=4)		1		organism-based format	Scientific Literature
13.	ALA815436	F	Inhibition expressed as percent change in diastolic blood pressure increased by AVP (30 milliunits / kg, iv) before and after oral administration at 79 uM/kg (n=7)		1		organism-based format	Scientific Literature
14.	ALA815437	F	Inhibition expressed as percent change in diastolic blood pressure increased by AVP (30 milliunits / kg, iv) before and after oral administration at uM/kg		1		organism-based format	Scientific Literature
15.	ALA815438	B	Binding potency against V1 receptor in rat liver cells		2		cell-based format	Scientific Literature
16.	ALA815439	B	Inhibition of the 3 nM VP stimulation of phospholipase-C in cultured WRK cells was used as a V1-mediated assay		1		cell-based format	Scientific Literature
17.	ALA815440	B	Relative affinity of compound expressed in percent compared to vasopressin		2		assay format	Scientific Literature
18.	ALA815441	B	Negative log of Kd.		2		single protein format	Scientific Literature
19.	ALA815443	B	Evaluated for the binding affinity towards vasopressin (V1A) receptor in rat liver membrane using [3H]AVP as radioligand	Rattus norvegicus	11		cell membrane format	Scientific Literature
20.	ALA815446	B	Concentration required to displace 50% of [3H]arginine vasopressin from rat liver arginine vasopressin 1A (AVP-V1a) site.		23		assay format	Scientific Literature